Risedronate Sodium Hydrate Tablet 150 mg

Adult dose

1. Adults: Administer 150 mg of risedronate sodium orally once a month. 2. Older adults: No dosage adjustment is necessary in older adults (over 60 years of age), as the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. ○ Since food interferes with the absorption of this medicine, take it at least 30 minutes before consuming any food or beverages other than water for the first time that day, to ensure adequate absorption. To allow this medicine to reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with plenty of plain water (170 ∼ 230 mL). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled day, take it as follows. - If the next scheduled dose is 7 days or more away, take 1 tablet the next morning after remembering. Take the next dose on the originally scheduled day. Do not take more than 1 tablet of this medicine within 7 days. - If the next scheduled dose is within 7 days, wait until the originally scheduled day and then take 1 tablet.

Child dose

3. Children: The safety and efficacy of this medicine in children under 18 years of age have not been established.

This medication may irritate the mucous membranes of the stomach and esophagus; therefore, caution is especially advised for patients with gastritis or esophageal disorders. When taking this medication, it should be taken with a sufficient amount of water, and the patient should not lie down for at least 30 minutes after taking it. If symptoms such as pain or discomfort in the esophagus, dysphagia occur, immediately discontinue use and consult a physician. This medication should not be used by patients with certain conditions, for example, esophageal strictures, hypocalcemia, severe renal impairment, women who are pregnant or likely to become pregnant, and nursing mothers. Prior to taking this medication, conditions such as hypocalcemia or vitamin D deficiency that affect calcium and bone metabolism should be treated, and it is important to ensure adequate intake of calcium and vitamin D. With long-term use, rare but serious side effects such as osteonecrosis of the jaw or atypical fractures may occur, so any unusual symptoms should be reported to a physician immediately. This medication may interfere with the absorption of other drugs, so it is advisable to take it at least 30 minutes apart from medications or foods containing calcium, magnesium, or iron. For women who are pregnant or breastfeeding, it is safest not to take this medication, and they should consult a physician if necessary. Safety for use in children under 18 years has not been established, and its use is not recommended. In case of overdose, symptoms of hypocalcemia may occur, so it is important to visit a medical institution for appropriate treatment immediately. This medication should be stored out of reach of children, and it is best not to switch containers arbitrarily.

• esophagitis
• esophageal ulcer
• esophageal erosion
• esophageal obstruction
• esophageal perforation
• gastric ulcer
• duodenal ulcer
• infection
• back pain
• accidental injury

This medication should be stored in a tightly sealed container to prevent air from entering, and should be kept at room temperature between 1 to 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained for a longer period.

Appearance

Bright blue oblong film-coated tablet

Package unit

1 tablet (1 tablet/PTP packaging)